CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,327 | +27.8% | 48,685 | +4.4% | 0.00% | – |
| Q2 2023 | $1,038 | +4.5% | 46,643 | +1.8% | 0.00% | – |
| Q1 2023 | $993 | +12.1% | 45,811 | +5.0% | 0.00% | – |
| Q4 2022 | $886 | -99.9% | 43,610 | +5.0% | 0.00% | – |
| Q3 2022 | $1,065,000 | +25.1% | 41,528 | +16.0% | 0.00% | – |
| Q2 2022 | $851,000 | +32.3% | 35,797 | +25.3% | 0.00% | – |
| Q1 2022 | $643,000 | +32.3% | 28,567 | +16.4% | 0.00% | – |
| Q4 2021 | $486,000 | -42.3% | 24,537 | -42.6% | 0.00% | – |
| Q3 2021 | $842,000 | -10.0% | 42,763 | +0.5% | 0.00% | – |
| Q2 2021 | $936,000 | -4.0% | 42,563 | +3.8% | 0.00% | – |
| Q1 2021 | $975,000 | -9.4% | 41,002 | -0.3% | 0.00% | – |
| Q4 2020 | $1,076,000 | +66.8% | 41,137 | -53.7% | 0.00% | – |
| Q4 2016 | $645,000 | +37.2% | 88,815 | -11.6% | 0.00% | – |
| Q1 2016 | $470,000 | -6.0% | 100,454 | 0.0% | 0.00% | – |
| Q4 2015 | $500,000 | -65.6% | 100,454 | -74.0% | 0.00% | – |
| Q3 2015 | $1,454,000 | – | 386,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |